This map shows the geographic impact of Jennings Fw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennings Fw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennings Fw more than expected).
This network shows the impact of papers produced by Jennings Fw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennings Fw. The network helps show where Jennings Fw may publish in the future.
Co-authorship network of co-authors of Jennings Fw
This figure shows the co-authorship network connecting the top 25 collaborators of Jennings Fw.
A scholar is included among the top collaborators of Jennings Fw based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Jennings Fw. Jennings Fw is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
14 of 14 papers shown
1.
Fw, Jennings. (1992). Chemotherapy of CNS-trypanosomiasis: the combined use of diminazene aceturate or pentamidine with DL-alpha-difluoromethylornithine (DFMO).. PubMed. 43(2). 106–9.5 indexed citations
2.
Fw, Jennings. (1991). Chemotherapy of trypanosomiasis: the potentiation of antimonial compounds by difluoromethylornithine (DFMO).. PubMed. 42(2). 135–8.5 indexed citations
3.
Fw, Jennings. (1991). Chemotherapy of CNS-trypanosomiasis: the combined use of the arsenicals and nitro-compounds.. PubMed. 42(2). 139–42.11 indexed citations
4.
Fw, Jennings. (1991). Chemotherapy of CNS-trypanosomiasis: combination chemotherapy with a 5-nitroimidazole (MK 436), an arsenical (Cymelarsan) and suramin.. PubMed. 42(3). 157–60.8 indexed citations
5.
Fw, Jennings, et al.. (1988). The relapse of Trypanosoma brucei brucei infections after chemotherapy in rabbits.. PubMed. 45(1). 45–54.4 indexed citations
6.
Fw, Jennings, Peter Ulrich, & Anthony Cerami. (1987). Chemotherapy of trypanosomiasis: the use of guanylhydrazone compounds in the treatment of experimental murine trypanosomiasis.. PubMed. 38(3). 181–6.3 indexed citations
7.
Fw, Jennings, et al.. (1983). Relapsed parasitaemia following chemotherapy of chronic T. brucei infections in mice and its relation to cerebral trypanosomes.. PubMed. 7. 147–54.87 indexed citations
8.
Fw, Jennings, J. Armour, & G.M. Urquhart. (1967). Larval inhibition in ostertagiasis.. PubMed. 57(4). 20P–20P.1 indexed citations
9.
Anderson, N., et al.. (1967). Experimental infections of Ostertagia ostertagi in calves: results of two regimens of multiple innoculations.. PubMed. 28(125). 1073–7.18 indexed citations
10.
Anderson, N., et al.. (1966). Experimental Ostertagia ostertagi infections in calves: parasitology and pathogenesis of a single infection.. PubMed. 27(118). 659–67.111 indexed citations
11.
Anderson, N., et al.. (1965). A field study of parasitic gastritis in cattle.. PubMed. 77(41). 1196–204.162 indexed citations
12.
Wf, Jarrett, et al.. (1962). The production of immunity to Cysticercus fasciolaris, using x-irradiated oncospheres.. PubMed. 23. 146–9.13 indexed citations
13.
Wf, Jarrett, et al.. (1961). Studies on immunity to Haemonchus contortus infection--double vaccination of sheep with irradiated larvae.. PubMed. 22. 186–8.34 indexed citations
14.
Fw, Jennings, et al.. (1954). Species differences in the intercellular plasma of the packed cell column.. PubMed. 59(334th Meeting). iii–iii.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.